FDA, Weight loss and diabetes drugs

Supplies of high-demand obesity treatments are improving, but that doesn’t mean it's easier to get them. Many employers and ...
Patients on semaglutide ( Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic ...
Few things have stirred up as much commotion in either the weight loss or pharmaceutical world as Ozempic and Wegovy. There's a good reason for that — these drugs have proven to be highly ...
The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.